Author

Orly Weinreb

Observed names: O Weinreb, O. Weinreb, ORLY WEINREB

Observed institutions: Radboud University Nijmegen, University of Waterloo, University of California, Los Angeles, Technion – Israel Institute of Technology, Rappaport Family Institute for Research in the Medical Sciences, Sha'ar Menashe Mental Health Center

ORCID: 0000-0003-1405-9612

Observed ORCIDs: 0000-0003-1405-9612, 0009-0006-6153-8914

OpenAlex ID: A5082642183

Green tea polyphenol (–)‐epigallocatechin‐3‐gallate prevents N ‐methyl‐4‐phenyl‐1,2,3,6‐tetrahydropyridine‐induced dopaminergic neurodegeneration

2001 · Yona Levites, Orly Weinreb, et al. · Journal of Neurochemistry · 567

Neurological mechanisms of green tea polyphenols in Alzheimer's and Parkinson's diseases

2004 · Orly Weinreb, Silvia Mandel, et al. · The Journal of Nutritional Biochemistry · 506

Cell signaling pathways in the neuroprotective actions of the green tea polyphenol (‐)‐epigallocatechin‐3‐gallate: implications for neurodegenerative diseases

2004 · Silvia Mandel, Orly Weinreb, et al. · Journal of Neurochemistry · 378

Multifunctional Activities of Green Tea Catechins in Neuroprotection

2005 · Silvia A. Mandel, Yael Avramovich-Tirosh, et al. · Neurosignals · 347

Green tea catechins as brain‐permeable, natural iron chelators‐antioxidants for the treatment of neurodegenerative disorders

2006 · Silvia Mandel, Tamar Amit, et al. · Molecular Nutrition & Food Research · 291

Neuroprotective molecular mechanisms of (−)-epigallocatechin-3-gallate: a reflective outcome of its antioxidant, iron chelating and neuritogenic properties

2009 · Orly Weinreb, Tamar Amit, et al. · Genes & Nutrition · 242

PDF

Simultaneous Manipulation of Multiple Brain Targets by Green Tea Catechins: A Potential Neuroprotective Strategy for Alzheimer and Parkinson Diseases

2008 · Silvia A. Mandel, Tamar Amit, et al. · CNS Neuroscience & Therapeutics · 221

PDF

Targeting dysregulation of brain iron homeostasis in Parkinson's disease by iron chelators

2013 · Orly Weinreb, Silvia Mandel, et al. · Free Radical Biology and Medicine · 190

Reduction of iron‐regulated amyloid precursor protein and β‐amyloid peptide by (–)‐epigallocatechin‐3‐gallate in cell cultures: implications for iron chelation in Alzheimer's disease

2006 · L. Reznichenko, T. Amit, et al. · Journal of Neurochemistry · 189

PDF

Neuroprotection via pro‐survival protein kinase C isoforms associated with Bcl‐2 family members

2004 · Orly Weinreb, Orit Bar‐Am, et al. · The FASEB Journal · 187

Cell Signaling Pathways and Iron Chelation in the Neurorestorative Activity of Green Tea Polyphenols: Special Reference to Epigallocatechin Gallate (EGCG)

2008 · Silvia A. Mandel, Tamar Amit, et al. · Journal of Alzheimer s Disease · 173

Rasagiline: A novel anti-Parkinsonian monoamine oxidase-B inhibitor with neuroprotective activity

2010 · Orly Weinreb, Tamar Amit, et al. · Progress in Neurobiology · 171

Rasagiline: Neurodegeneration, neuroprotection, and mitochondrial permeability transition

2004 · Moussa B.H. Youdim, Orit Bar Am, et al. · Journal of Neuroscience Research · 166

Regulation of Bcl‐2 family proteins, neurotrophic factors, and APP processing in the neurorescue activity of propargylamine

2005 · Orit Bar‐Am, Orly Weinreb, et al. · The FASEB Journal · 165

Mechanism of neuroprotective action of the anti-Parkinson drug rasagiline and its derivatives

2005 · Silvia Mandel, Orly Weinreb, et al. · Brain Research Reviews · 157

Ladostigil: A Novel Multimodal Neuroprotective Drug with Cholinesterase and Brain-Selective Monoamine Oxidase Inhibitory Activities for Alzheimers Disease Treatment

2012 · Orly Weinreb, Tamar Amit, et al. · Current Drug Targets · 153

Understanding the Broad-Spectrum Neuroprotective Action Profile of Green Tea Polyphenols in Aging and Neurodegenerative Diseases

2011 · Silvia A. Mandel, Tamar Amit, et al. · Journal of Alzheimer s Disease · 143

Neuroprotective and neuritogenic activities of novel multimodal iron‐chelating drugs in motor‐neuron‐like NSC‐34 cells and transgenic mouse model of amyotrophic lateral sclerosis

2009 · Lana Kupershmidt, Orly Weinreb, et al. · The FASEB Journal · 123

cDNA gene expression profile homology of antioxidants and their antiapoptotic and proapoptotic activities in human neuroblastoma cells

2003 · Orly Weinreb, Silvia Mandel, et al. · The FASEB Journal · 120

Propargylamine Containing Compounds as Modulators of Proteolytic Cleavage of Amyloid Protein Precursor: Involvement of MAPK and PKC Activation

2010 · Orit Bar-Am, Tamar Amit, et al. · Journal of Alzheimer s Disease · 111

Multifunctional Neuroprotective Derivatives of Rasagiline as Anti-Alzheimer's Disease Drugs

2008 · Orly Weinreb, Silvia Mandel, et al. · Neurotherapeutics · 109

PDF

DJ ‐1 deficiency triggers microglia sensitivity to dopamine toward a pro‐inflammatory phenotype that is attenuated by rasagiline

2013 · Dorit Trudler, Orly Weinreb, et al. · Journal of Neurochemistry · 108

Neurorescue Activity, APP Regulation and Amyloid-β Peptide Reduction by Novel Multi-Functional Brain Permeable Iron- Chelating- Antioxidants,M-30 and Green Tea Polyphenol, EGCG

2007 · Yael Avramovich-Tirosh, Lydia Reznichenko, et al. · Current Alzheimer Research · 107

Induction of Neurotrophic Factors GDNF and BDNF Associated with the Mechanism of Neurorescue Action of Rasagiline and Ladostigil

2007 · ORLY WEINREB, TAMAR AMIT, et al. · Annals of the New York Academy of Sciences · 93

Neuroprotective and neurorestorative activities of a novel iron chelator-brain selective monoamine oxidase-A/monoamine oxidase-B inhibitor in animal models of Parkinson's disease and aging

2014 · Orit Bar-Am, Tamar Amit, et al. · Neurobiology of Aging · 88

Works count: 135

Citation count: 7,798

H-index: 46

I10-index: 94